13F filerCIK 1061768 ↗
Baupost Group
You are looking at Q2 2018. See the latest, Q3 2026 →
Reported value
$11.44B
+10% on the quarter before
Positions
33
6 new, 6 sold out
Top 10
76.7%
of the value
Est. gain
+$752.0M
on stocks held all quarter
Est. return
+8.7%
on those stocks since Q1 2018
Positions as of Jun 30, 2018, from Baupost Group's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q1 2018. Striped tiles are options.
Largest buys
Since Q1 2018, sized at quarter-end prices.
- Twenty First Centy Fox Inc~$637.4MAdded, 9.4% → 17.1% of the portfolio+12,827,098 shares
- Colony Cap Inc New~$310.0MNew, 0.0% → 2.7% of the portfolio+49,687,370 shares
- AT&T~$304.4MNew, 0.0% → 2.7% of the portfolio+9,480,700 shares
- Tesla~$245.0MAdded, 0.5% → 2.7% of the portfolio+200,000,000 shares
- Tribune Media Co~$114.7MNew, 0.0% → 1.0% of the portfolio+2,996,042 shares
- Twenty First Centy Fox Inc~$107.1MAdded, 4.0% → 5.9% of the portfolio+2,172,902 shares
- Sinclair Broadcast Group Inc~$82.7MNew, 0.0% → 0.7% of the portfolio+2,571,302 shares
- Pg&E Corp~$57.5MAdded, 1.3% → 1.7% of the portfolio+1,350,028 shares
- Amerisourcebergen Corp~$47.4MAdded, 1.1% → 1.4% of the portfolio+556,349 shares
- Allergan Plc~$33.3MAdded, 7.7% → 7.2% of the portfolio+200,000 shares
Largest sells
Since Q1 2018, sized at quarter-end prices.
- Time Warner Inc~$766.1MSold out, 7.4% → 0.0% of the portfolio−8,100,000 shares
- Cheniere Energy Inc~$425.7MCut, 10.7% → 8.1% of the portfolio−6,530,205 shares
- Colony Northstar Inc~$279.2MSold out, 2.7% → 0.0% of the portfolio−49,687,370 shares
- Pbf Energy Inc~$268.6MSold out, 2.6% → 0.0% of the portfolio−7,924,175 shares
- ChipMOS Technologies~$14.8MSold out, 0.1% → 0.0% of the portfolio−933,658 shares
- Forward Pharma A/S~$6.2MSold out, 0.1% → 0.0% of the portfolio−2,848,003 shares
- Orexigen Therapeutics Inc~$465,000Sold out, 0.0% → 0.0% of the portfolio−2,226,839 shares
Holdings
As of Jun 30, 2018; changes in shares since Mar 31, 2018.
| Holding | Value | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Twenty First Centy Fox IncCL A · shares +48% · price +35.4% | 17.1% | $1.96B | +$345.7M | ||||||
| Synchrony FinlCOM · shares 0% · price −0.4% | 8.5% | $977.9M | −$4.4M | ||||||
| Cheniere Energy IncCOM NEW · shares −32% · price +22.0% | 8.1% | $925.4M | +$166.7M | ||||||
| Viasat IncCOM · shares +0.5% · price +0.0% | 7.9% | $902.5M | +$252.04 | ||||||
| QorvoCOM · shares 0% · price +13.8% | 7.7% | $881.9M | +$106.9M | ||||||
| Allergan PlcSHS · shares +4.2% · price −0.9% | 7.2% | $825.3M | −$7.5M | ||||||
| Pioneer Nat Res CoCOM · shares 0% · price +10.2% | 6.6% | $757.0M | +$69.8M | ||||||
| Twenty First Centy Fox IncCL B · shares +19% · price +35.5% | 5.9% | $670.4M | +$147.5M | ||||||
| Antero Res CorpCOM · shares 0% · price +7.6% | 5.0% | $567.6M | +$39.9M | ||||||
| Colony Cap Inc NewCL A COM · shares New | 2.7% | $310.0M | — | ||||||
| TeslaNOTE 2.375% 3/1 · shares +400% · price +17.4% | 2.7% | $306.3M | — | ||||||
| AT&TCOM · shares New | 2.7% | $304.4M | — | ||||||
| Cardinal Health IncCOM · shares 0% · price −22.1% | 2.2% | $249.0M | −$70.6M | ||||||
| Atara Biotherapeutics IncCOM · shares 0% · price −5.8% | 2.0% | $229.9M | −$14.1M | ||||||
| Mckesson CorpCOM · shares +0.7% · price −5.3% | 1.9% | $217.1M | −$12.1M | ||||||
| Theravance Biopharma IncCOM · shares 0% · price −6.5% | 1.8% | $211.1M | −$14.6M | ||||||
| Pg&E CorpCOM · shares +43% · price −3.1% | 1.7% | $191.5M | −$4.3M | ||||||
| Amerisourcebergen CorpCOM · shares +42% · price −1.1% | 1.4% | $159.8M | −$1.2M | ||||||
| Veritiv CorpCOM · shares 0% · price +1.7% | 1.3% | $152.4M | +$2.5M | ||||||
| Tribune Media CoCL A · shares New | 1.0% | $114.7M | — | ||||||
| Keryx Biopharmaceuticals IncCOM · shares 0% · price −8.1% | 0.85% | $97.0M | −$8.5M | ||||||
| Sinclair Broadcast Group IncCL A · shares New | 0.72% | $82.7M | — | ||||||
| Amc Entmt Hldgs IncCL A COM · shares 0% · price +13.2% | 0.70% | $79.5M | +$9.2M | ||||||
| Novagold Res IncCOM NEW · shares 0% · price +2.8% | 0.52% | $59.9M | +$1.6M | ||||||
| Gty Technology Holdings IncUNIT 99/99/9999 · shares 0% · price +0.8% | 0.40% | $45.9M | +$352,000 | ||||||
| Total 33 positions | 100% | $11.44B | +$752.0M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2018 to Q2 2018: 25 stocks held throughout, up $752.0M (+8.7%).
- Twenty First Centy Fox Inc+$345.7M+35%
- Cheniere Energy Inc+$166.7M+22%
- Twenty First Centy Fox Inc+$147.5M+35%
- Qorvo+$106.9M+14%
- Pioneer Nat Res Co+$69.8M+10%
- Keryx Biopharmaceuticals Inc−$8.5M−8%
- Mckesson Corp−$12.1M−5%
- Atara Biotherapeutics Inc−$14.1M−6%
- Theravance Biopharma Inc−$14.6M−6%
- Cardinal Health Inc−$70.6M−22%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Nov 13, 2026 | $5.05B−7% | SEC ↗ |
| Q2 2026 | Aug 13, 2026 | $5.42B+6% | SEC ↗ |
| Q1 2026 | May 14, 2026 | $5.12B−3% | SEC ↗ |
| Q4 2025 | Feb 13, 2026 | $5.28B+10% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $4.79B+16% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $4.13B+18% | SEC ↗ |
| Q1 2025 | May 14, 2025 | $3.50B+2% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $3.43B−2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $3.52B−3% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $3.63B−0% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $3.65B−20% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $4.59B−12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $5.21B−7% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $5.61B−4% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $5.85B−5% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $6.13B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $5.79B−14% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $6.77B−27% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $9.30B−8% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $10.13B−7% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $10.88B−12% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $12.33B−2% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $12.56B+16% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $10.84B+17% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $9.25B+15% | SEC ↗ |
| Q2 2020 | Aug 13, 2020 | $8.01B+18% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $6.77B−25% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $9.06B+3% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $8.83B−20% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $11.05B−7% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $11.90B+3% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 | $11.52B−12% | SEC ↗ |
| Q3 2018 | Nov 15, 2018 (amended) | $13.06B+14% | SEC ↗ |
| Q2 2018 | Aug 13, 2018 | $11.44B+10% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $10.37B+3% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $10.11B+26% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $8.02B−8% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $8.75B+3% | SEC ↗ |
| Q1 2017 | May 25, 2017 (amended) | $8.49B+11% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $7.67B+9% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $7.04B−4% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $7.37B+6% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $6.92B | SEC ↗ |